Derma gets FDA OK for antimicrobial silver alginate wound dressing

By Elaine Rigoli

Tampa, Fla., Sept. 19 - Derma Sciences, Inc. announced Food and Drug Administration approval of Algicell Ag Calcium Alginate Wound Dressing with Antimicrobial Silver for patients who require a topical antimicrobial as part of their advanced wound management protocol.

Advanced wound care is estimated to be a $1 billion market and growing 10% to 15% per year, according to a news release.

This will be the first silver alginate dressing available that offers the full benefit of antimicrobial ionic silver combined with the proven wound management properties of pure alginate fibers, the release said.

Additionally, the product will be priced cost-effectively to help reduce the common cost burden associated with silver antimicrobial dressings.

The Princeton, N.J., pharmaceutical company said Algicell Ag is made up of 1.4% silver - released in its ionic form - and a proprietary blend of mannuronic and guluronic alginic acids.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.